Global Pediatric Growth Hormone Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Pediatric Growth Hormone Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 86

Published Date: 17 May 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Pediatric Growth Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pediatric Growth Hormone market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital Pharmacies accounting for % of the Pediatric Growth Hormone global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Growth Hormone Deficiency segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Pediatric Growth Hormone include Merck KGaA, Novo Nordisk A/S, Ferring B.V, Genentech, Inc., and Pfizer Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Pediatric Growth Hormone market is split by Indication and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Indication and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Indication, covers
Growth Hormone Deficiency
Turner Syndrome
Prader-Willi Syndrome
Noonan Syndrome
Others

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Market segment by players, this report covers
Merck KGaA
Novo Nordisk A/S
Ferring B.V
Genentech, Inc.
Pfizer Inc.
Eli Lilly & Company
Novartis AG
BioPartners GmbH

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pediatric Growth Hormone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pediatric Growth Hormone, with revenue, gross margin and global market share of Pediatric Growth Hormone from 2019 to 2022.
Chapter 3, the Pediatric Growth Hormone competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Indication and application, with revenue and growth rate by Indication, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pediatric Growth Hormone market forecast, by regions, indication and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pediatric Growth Hormone research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Pediatric Growth Hormone
1.2 Classification of Pediatric Growth Hormone by Indication
1.2.1 Overview: Global Pediatric Growth Hormone Market Size by Indication: 2017 Versus 2021 Versus 2028
1.2.2 Global Pediatric Growth Hormone Revenue Market Share by Indication in 2021
1.2.3 Growth Hormone Deficiency
1.2.4 Turner Syndrome
1.2.5 Prader-Willi Syndrome
1.2.6 Noonan Syndrome
1.2.7 Others
1.3 Global Pediatric Growth Hormone Market by Application
1.3.1 Overview: Global Pediatric Growth Hormone Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Pediatric Growth Hormone Market Size & Forecast
1.5 Global Pediatric Growth Hormone Market Size and Forecast by Region
1.5.1 Global Pediatric Growth Hormone Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pediatric Growth Hormone Market Size by Region, (2017-2022)
1.5.3 North America Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.4 Europe Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.6 South America Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pediatric Growth Hormone Market Drivers
1.6.2 Pediatric Growth Hormone Market Restraints
1.6.3 Pediatric Growth Hormone Trends Analysis

2 Company Profiles
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business
2.1.3 Merck KGaA Pediatric Growth Hormone Product and Solutions
2.1.4 Merck KGaA Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Merck KGaA Recent Developments and Future Plans
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business
2.2.3 Novo Nordisk A/S Pediatric Growth Hormone Product and Solutions
2.2.4 Novo Nordisk A/S Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novo Nordisk A/S Recent Developments and Future Plans
2.3 Ferring B.V
2.3.1 Ferring B.V Details
2.3.2 Ferring B.V Major Business
2.3.3 Ferring B.V Pediatric Growth Hormone Product and Solutions
2.3.4 Ferring B.V Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Ferring B.V Recent Developments and Future Plans
2.4 Genentech, Inc.
2.4.1 Genentech, Inc. Details
2.4.2 Genentech, Inc. Major Business
2.4.3 Genentech, Inc. Pediatric Growth Hormone Product and Solutions
2.4.4 Genentech, Inc. Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Genentech, Inc. Recent Developments and Future Plans
2.5 Pfizer Inc.
2.5.1 Pfizer Inc. Details
2.5.2 Pfizer Inc. Major Business
2.5.3 Pfizer Inc. Pediatric Growth Hormone Product and Solutions
2.5.4 Pfizer Inc. Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pfizer Inc. Recent Developments and Future Plans
2.6 Eli Lilly & Company
2.6.1 Eli Lilly & Company Details
2.6.2 Eli Lilly & Company Major Business
2.6.3 Eli Lilly & Company Pediatric Growth Hormone Product and Solutions
2.6.4 Eli Lilly & Company Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eli Lilly & Company Recent Developments and Future Plans
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business
2.7.3 Novartis AG Pediatric Growth Hormone Product and Solutions
2.7.4 Novartis AG Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novartis AG Recent Developments and Future Plans
2.8 BioPartners GmbH
2.8.1 BioPartners GmbH Details
2.8.2 BioPartners GmbH Major Business
2.8.3 BioPartners GmbH Pediatric Growth Hormone Product and Solutions
2.8.4 BioPartners GmbH Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 BioPartners GmbH Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Pediatric Growth Hormone Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pediatric Growth Hormone Players Market Share in 2021
3.2.2 Top 10 Pediatric Growth Hormone Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pediatric Growth Hormone Players Head Office, Products and Services Provided
3.4 Pediatric Growth Hormone Mergers & Acquisitions
3.5 Pediatric Growth Hormone New Entrants and Expansion Plans

4 Market Size Segment by Indication
4.1 Global Pediatric Growth Hormone Revenue and Market Share by Indication (2017-2022)
4.2 Global Pediatric Growth Hormone Market Forecast by Indication (2023-2028)

5 Market Size Segment by Application
5.1 Global Pediatric Growth Hormone Revenue Market Share by Application (2017-2022)
5.2 Global Pediatric Growth Hormone Market Forecast by Application (2023-2028)

6 North America by Country, by Indication, and by Application
6.1 North America Pediatric Growth Hormone Revenue by Indication (2017-2028)
6.2 North America Pediatric Growth Hormone Revenue by Application (2017-2028)
6.3 North America Pediatric Growth Hormone Market Size by Country
6.3.1 North America Pediatric Growth Hormone Revenue by Country (2017-2028)
6.3.2 United States Pediatric Growth Hormone Market Size and Forecast (2017-2028)
6.3.3 Canada Pediatric Growth Hormone Market Size and Forecast (2017-2028)
6.3.4 Mexico Pediatric Growth Hormone Market Size and Forecast (2017-2028)

7 Europe by Country, by Indication, and by Application
7.1 Europe Pediatric Growth Hormone Revenue by Indication (2017-2028)
7.2 Europe Pediatric Growth Hormone Revenue by Application (2017-2028)
7.3 Europe Pediatric Growth Hormone Market Size by Country
7.3.1 Europe Pediatric Growth Hormone Revenue by Country (2017-2028)
7.3.2 Germany Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.3 France Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.5 Russia Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.6 Italy Pediatric Growth Hormone Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Indication, and by Application
8.1 Asia-Pacific Pediatric Growth Hormone Revenue by Indication (2017-2028)
8.2 Asia-Pacific Pediatric Growth Hormone Revenue by Application (2017-2028)
8.3 Asia-Pacific Pediatric Growth Hormone Market Size by Region
8.3.1 Asia-Pacific Pediatric Growth Hormone Revenue by Region (2017-2028)
8.3.2 China Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.3 Japan Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.4 South Korea Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.5 India Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.7 Australia Pediatric Growth Hormone Market Size and Forecast (2017-2028)

9 South America by Country, by Indication, and by Application
9.1 South America Pediatric Growth Hormone Revenue by Indication (2017-2028)
9.2 South America Pediatric Growth Hormone Revenue by Application (2017-2028)
9.3 South America Pediatric Growth Hormone Market Size by Country
9.3.1 South America Pediatric Growth Hormone Revenue by Country (2017-2028)
9.3.2 Brazil Pediatric Growth Hormone Market Size and Forecast (2017-2028)
9.3.3 Argentina Pediatric Growth Hormone Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Indication, and by Application
10.1 Middle East & Africa Pediatric Growth Hormone Revenue by Indication (2017-2028)
10.2 Middle East & Africa Pediatric Growth Hormone Revenue by Application (2017-2028)
10.3 Middle East & Africa Pediatric Growth Hormone Market Size by Country
10.3.1 Middle East & Africa Pediatric Growth Hormone Revenue by Country (2017-2028)
10.3.2 Turkey Pediatric Growth Hormone Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pediatric Growth Hormone Market Size and Forecast (2017-2028)
10.3.4 UAE Pediatric Growth Hormone Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Pediatric Growth Hormone Revenue by Indication, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pediatric Growth Hormone Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pediatric Growth Hormone Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pediatric Growth Hormone Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pediatric Growth Hormone Revenue Market Share by Region (2023-2028)
Table 6. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 7. Merck KGaA Major Business
Table 8. Merck KGaA Pediatric Growth Hormone Product and Solutions
Table 9. Merck KGaA Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novo Nordisk A/S Corporate Information, Head Office, and Major Competitors
Table 11. Novo Nordisk A/S Major Business
Table 12. Novo Nordisk A/S Pediatric Growth Hormone Product and Solutions
Table 13. Novo Nordisk A/S Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Ferring B.V Corporate Information, Head Office, and Major Competitors
Table 15. Ferring B.V Major Business
Table 16. Ferring B.V Pediatric Growth Hormone Product and Solutions
Table 17. Ferring B.V Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Genentech, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Genentech, Inc. Major Business
Table 20. Genentech, Inc. Pediatric Growth Hormone Product and Solutions
Table 21. Genentech, Inc. Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Inc. Major Business
Table 24. Pfizer Inc. Pediatric Growth Hormone Product and Solutions
Table 25. Pfizer Inc. Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eli Lilly & Company Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly & Company Major Business
Table 28. Eli Lilly & Company Pediatric Growth Hormone Product and Solutions
Table 29. Eli Lilly & Company Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 31. Novartis AG Major Business
Table 32. Novartis AG Pediatric Growth Hormone Product and Solutions
Table 33. Novartis AG Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. BioPartners GmbH Corporate Information, Head Office, and Major Competitors
Table 35. BioPartners GmbH Major Business
Table 36. BioPartners GmbH Pediatric Growth Hormone Product and Solutions
Table 37. BioPartners GmbH Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Pediatric Growth Hormone Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Pediatric Growth Hormone Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Pediatric Growth Hormone by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Pediatric Growth Hormone Players Head Office, Products and Services Provided
Table 42. Pediatric Growth Hormone Mergers & Acquisitions in the Past Five Years
Table 43. Pediatric Growth Hormone New Entrants and Expansion Plans
Table 44. Global Pediatric Growth Hormone Revenue (USD Million) by Indication (2017-2022)
Table 45. Global Pediatric Growth Hormone Revenue Share by Indication (2017-2022)
Table 46. Global Pediatric Growth Hormone Revenue Forecast by Indication (2023-2028)
Table 47. Global Pediatric Growth Hormone Revenue by Application (2017-2022)
Table 48. Global Pediatric Growth Hormone Revenue Forecast by Application (2023-2028)
Table 49. North America Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 50. North America Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 51. North America Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 56. Europe Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 57. Europe Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 62. Asia-Pacific Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 63. Asia-Pacific Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Pediatric Growth Hormone Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Pediatric Growth Hormone Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 68. South America Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 69. South America Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 74. Middle East & Africa Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 75. Middle East & Africa Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pediatric Growth Hormone Picture
Figure 2. Global Pediatric Growth Hormone Revenue Market Share by Indication in 2021
Figure 3. Growth Hormone Deficiency
Figure 4. Turner Syndrome
Figure 5. Prader-Willi Syndrome
Figure 6. Noonan Syndrome
Figure 7. Others
Figure 8. Pediatric Growth Hormone Revenue Market Share by Application in 2021
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Others Picture
Figure 13. Global Pediatric Growth Hormone Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Pediatric Growth Hormone Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Pediatric Growth Hormone Revenue Market Share by Region (2017-2028)
Figure 16. Global Pediatric Growth Hormone Revenue Market Share by Region in 2021
Figure 17. North America Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Pediatric Growth Hormone Market Drivers
Figure 23. Pediatric Growth Hormone Market Restraints
Figure 24. Pediatric Growth Hormone Market Trends
Figure 25. Merck KGaA Recent Developments and Future Plans
Figure 26. Novo Nordisk A/S Recent Developments and Future Plans
Figure 27. Ferring B.V Recent Developments and Future Plans
Figure 28. Genentech, Inc. Recent Developments and Future Plans
Figure 29. Pfizer Inc. Recent Developments and Future Plans
Figure 30. Eli Lilly & Company Recent Developments and Future Plans
Figure 31. Novartis AG Recent Developments and Future Plans
Figure 32. BioPartners GmbH Recent Developments and Future Plans
Figure 33. Global Pediatric Growth Hormone Revenue Share by Players in 2021
Figure 34. Pediatric Growth Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Pediatric Growth Hormone Revenue Market Share in 2021
Figure 36. Global Top 10 Players Pediatric Growth Hormone Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Pediatric Growth Hormone Revenue Share by Indication in 2021
Figure 39. Global Pediatric Growth Hormone Market Share Forecast by Indication (2023-2028)
Figure 40. Global Pediatric Growth Hormone Revenue Share by Application in 2021
Figure 41. Global Pediatric Growth Hormone Market Share Forecast by Application (2023-2028)
Figure 42. North America Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 43. North America Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 44. North America Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 45. United States Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 49. Europe Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 50. Europe Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 51. Germany Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 57. Asia-Pacific Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Pediatric Growth Hormone Revenue Market Share by Region (2017-2028)
Figure 59. China Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 66. South America Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 67. South America Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 71. Middle East and Africa Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Merck KGaA
Novo Nordisk A/S
Ferring B.V
Genentech, Inc.
Pfizer Inc.
Eli Lilly & Company
Novartis AG
BioPartners GmbH
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Pediatric Growth Hormone Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Pediatric Growth Hormone Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 86

Published Date: 17 May 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Pediatric Growth Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pediatric Growth Hormone market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital Pharmacies accounting for % of the Pediatric Growth Hormone global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Growth Hormone Deficiency segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Pediatric Growth Hormone include Merck KGaA, Novo Nordisk A/S, Ferring B.V, Genentech, Inc., and Pfizer Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Pediatric Growth Hormone market is split by Indication and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Indication and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Indication, covers
Growth Hormone Deficiency
Turner Syndrome
Prader-Willi Syndrome
Noonan Syndrome
Others

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Market segment by players, this report covers
Merck KGaA
Novo Nordisk A/S
Ferring B.V
Genentech, Inc.
Pfizer Inc.
Eli Lilly & Company
Novartis AG
BioPartners GmbH

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pediatric Growth Hormone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pediatric Growth Hormone, with revenue, gross margin and global market share of Pediatric Growth Hormone from 2019 to 2022.
Chapter 3, the Pediatric Growth Hormone competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Indication and application, with revenue and growth rate by Indication, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pediatric Growth Hormone market forecast, by regions, indication and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pediatric Growth Hormone research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Pediatric Growth Hormone
1.2 Classification of Pediatric Growth Hormone by Indication
1.2.1 Overview: Global Pediatric Growth Hormone Market Size by Indication: 2017 Versus 2021 Versus 2028
1.2.2 Global Pediatric Growth Hormone Revenue Market Share by Indication in 2021
1.2.3 Growth Hormone Deficiency
1.2.4 Turner Syndrome
1.2.5 Prader-Willi Syndrome
1.2.6 Noonan Syndrome
1.2.7 Others
1.3 Global Pediatric Growth Hormone Market by Application
1.3.1 Overview: Global Pediatric Growth Hormone Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Pediatric Growth Hormone Market Size & Forecast
1.5 Global Pediatric Growth Hormone Market Size and Forecast by Region
1.5.1 Global Pediatric Growth Hormone Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pediatric Growth Hormone Market Size by Region, (2017-2022)
1.5.3 North America Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.4 Europe Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.6 South America Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pediatric Growth Hormone Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pediatric Growth Hormone Market Drivers
1.6.2 Pediatric Growth Hormone Market Restraints
1.6.3 Pediatric Growth Hormone Trends Analysis

2 Company Profiles
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business
2.1.3 Merck KGaA Pediatric Growth Hormone Product and Solutions
2.1.4 Merck KGaA Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Merck KGaA Recent Developments and Future Plans
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business
2.2.3 Novo Nordisk A/S Pediatric Growth Hormone Product and Solutions
2.2.4 Novo Nordisk A/S Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novo Nordisk A/S Recent Developments and Future Plans
2.3 Ferring B.V
2.3.1 Ferring B.V Details
2.3.2 Ferring B.V Major Business
2.3.3 Ferring B.V Pediatric Growth Hormone Product and Solutions
2.3.4 Ferring B.V Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Ferring B.V Recent Developments and Future Plans
2.4 Genentech, Inc.
2.4.1 Genentech, Inc. Details
2.4.2 Genentech, Inc. Major Business
2.4.3 Genentech, Inc. Pediatric Growth Hormone Product and Solutions
2.4.4 Genentech, Inc. Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Genentech, Inc. Recent Developments and Future Plans
2.5 Pfizer Inc.
2.5.1 Pfizer Inc. Details
2.5.2 Pfizer Inc. Major Business
2.5.3 Pfizer Inc. Pediatric Growth Hormone Product and Solutions
2.5.4 Pfizer Inc. Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pfizer Inc. Recent Developments and Future Plans
2.6 Eli Lilly & Company
2.6.1 Eli Lilly & Company Details
2.6.2 Eli Lilly & Company Major Business
2.6.3 Eli Lilly & Company Pediatric Growth Hormone Product and Solutions
2.6.4 Eli Lilly & Company Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eli Lilly & Company Recent Developments and Future Plans
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business
2.7.3 Novartis AG Pediatric Growth Hormone Product and Solutions
2.7.4 Novartis AG Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novartis AG Recent Developments and Future Plans
2.8 BioPartners GmbH
2.8.1 BioPartners GmbH Details
2.8.2 BioPartners GmbH Major Business
2.8.3 BioPartners GmbH Pediatric Growth Hormone Product and Solutions
2.8.4 BioPartners GmbH Pediatric Growth Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 BioPartners GmbH Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Pediatric Growth Hormone Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pediatric Growth Hormone Players Market Share in 2021
3.2.2 Top 10 Pediatric Growth Hormone Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pediatric Growth Hormone Players Head Office, Products and Services Provided
3.4 Pediatric Growth Hormone Mergers & Acquisitions
3.5 Pediatric Growth Hormone New Entrants and Expansion Plans

4 Market Size Segment by Indication
4.1 Global Pediatric Growth Hormone Revenue and Market Share by Indication (2017-2022)
4.2 Global Pediatric Growth Hormone Market Forecast by Indication (2023-2028)

5 Market Size Segment by Application
5.1 Global Pediatric Growth Hormone Revenue Market Share by Application (2017-2022)
5.2 Global Pediatric Growth Hormone Market Forecast by Application (2023-2028)

6 North America by Country, by Indication, and by Application
6.1 North America Pediatric Growth Hormone Revenue by Indication (2017-2028)
6.2 North America Pediatric Growth Hormone Revenue by Application (2017-2028)
6.3 North America Pediatric Growth Hormone Market Size by Country
6.3.1 North America Pediatric Growth Hormone Revenue by Country (2017-2028)
6.3.2 United States Pediatric Growth Hormone Market Size and Forecast (2017-2028)
6.3.3 Canada Pediatric Growth Hormone Market Size and Forecast (2017-2028)
6.3.4 Mexico Pediatric Growth Hormone Market Size and Forecast (2017-2028)

7 Europe by Country, by Indication, and by Application
7.1 Europe Pediatric Growth Hormone Revenue by Indication (2017-2028)
7.2 Europe Pediatric Growth Hormone Revenue by Application (2017-2028)
7.3 Europe Pediatric Growth Hormone Market Size by Country
7.3.1 Europe Pediatric Growth Hormone Revenue by Country (2017-2028)
7.3.2 Germany Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.3 France Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.5 Russia Pediatric Growth Hormone Market Size and Forecast (2017-2028)
7.3.6 Italy Pediatric Growth Hormone Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Indication, and by Application
8.1 Asia-Pacific Pediatric Growth Hormone Revenue by Indication (2017-2028)
8.2 Asia-Pacific Pediatric Growth Hormone Revenue by Application (2017-2028)
8.3 Asia-Pacific Pediatric Growth Hormone Market Size by Region
8.3.1 Asia-Pacific Pediatric Growth Hormone Revenue by Region (2017-2028)
8.3.2 China Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.3 Japan Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.4 South Korea Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.5 India Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pediatric Growth Hormone Market Size and Forecast (2017-2028)
8.3.7 Australia Pediatric Growth Hormone Market Size and Forecast (2017-2028)

9 South America by Country, by Indication, and by Application
9.1 South America Pediatric Growth Hormone Revenue by Indication (2017-2028)
9.2 South America Pediatric Growth Hormone Revenue by Application (2017-2028)
9.3 South America Pediatric Growth Hormone Market Size by Country
9.3.1 South America Pediatric Growth Hormone Revenue by Country (2017-2028)
9.3.2 Brazil Pediatric Growth Hormone Market Size and Forecast (2017-2028)
9.3.3 Argentina Pediatric Growth Hormone Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Indication, and by Application
10.1 Middle East & Africa Pediatric Growth Hormone Revenue by Indication (2017-2028)
10.2 Middle East & Africa Pediatric Growth Hormone Revenue by Application (2017-2028)
10.3 Middle East & Africa Pediatric Growth Hormone Market Size by Country
10.3.1 Middle East & Africa Pediatric Growth Hormone Revenue by Country (2017-2028)
10.3.2 Turkey Pediatric Growth Hormone Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pediatric Growth Hormone Market Size and Forecast (2017-2028)
10.3.4 UAE Pediatric Growth Hormone Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Pediatric Growth Hormone Revenue by Indication, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pediatric Growth Hormone Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pediatric Growth Hormone Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pediatric Growth Hormone Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pediatric Growth Hormone Revenue Market Share by Region (2023-2028)
Table 6. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 7. Merck KGaA Major Business
Table 8. Merck KGaA Pediatric Growth Hormone Product and Solutions
Table 9. Merck KGaA Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novo Nordisk A/S Corporate Information, Head Office, and Major Competitors
Table 11. Novo Nordisk A/S Major Business
Table 12. Novo Nordisk A/S Pediatric Growth Hormone Product and Solutions
Table 13. Novo Nordisk A/S Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Ferring B.V Corporate Information, Head Office, and Major Competitors
Table 15. Ferring B.V Major Business
Table 16. Ferring B.V Pediatric Growth Hormone Product and Solutions
Table 17. Ferring B.V Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Genentech, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Genentech, Inc. Major Business
Table 20. Genentech, Inc. Pediatric Growth Hormone Product and Solutions
Table 21. Genentech, Inc. Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Inc. Major Business
Table 24. Pfizer Inc. Pediatric Growth Hormone Product and Solutions
Table 25. Pfizer Inc. Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eli Lilly & Company Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly & Company Major Business
Table 28. Eli Lilly & Company Pediatric Growth Hormone Product and Solutions
Table 29. Eli Lilly & Company Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 31. Novartis AG Major Business
Table 32. Novartis AG Pediatric Growth Hormone Product and Solutions
Table 33. Novartis AG Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. BioPartners GmbH Corporate Information, Head Office, and Major Competitors
Table 35. BioPartners GmbH Major Business
Table 36. BioPartners GmbH Pediatric Growth Hormone Product and Solutions
Table 37. BioPartners GmbH Pediatric Growth Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Pediatric Growth Hormone Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Pediatric Growth Hormone Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Pediatric Growth Hormone by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Pediatric Growth Hormone Players Head Office, Products and Services Provided
Table 42. Pediatric Growth Hormone Mergers & Acquisitions in the Past Five Years
Table 43. Pediatric Growth Hormone New Entrants and Expansion Plans
Table 44. Global Pediatric Growth Hormone Revenue (USD Million) by Indication (2017-2022)
Table 45. Global Pediatric Growth Hormone Revenue Share by Indication (2017-2022)
Table 46. Global Pediatric Growth Hormone Revenue Forecast by Indication (2023-2028)
Table 47. Global Pediatric Growth Hormone Revenue by Application (2017-2022)
Table 48. Global Pediatric Growth Hormone Revenue Forecast by Application (2023-2028)
Table 49. North America Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 50. North America Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 51. North America Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 56. Europe Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 57. Europe Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 62. Asia-Pacific Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 63. Asia-Pacific Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Pediatric Growth Hormone Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Pediatric Growth Hormone Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 68. South America Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 69. South America Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Pediatric Growth Hormone Revenue by Indication (2017-2022) & (USD Million)
Table 74. Middle East & Africa Pediatric Growth Hormone Revenue by Indication (2023-2028) & (USD Million)
Table 75. Middle East & Africa Pediatric Growth Hormone Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Pediatric Growth Hormone Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Pediatric Growth Hormone Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Pediatric Growth Hormone Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pediatric Growth Hormone Picture
Figure 2. Global Pediatric Growth Hormone Revenue Market Share by Indication in 2021
Figure 3. Growth Hormone Deficiency
Figure 4. Turner Syndrome
Figure 5. Prader-Willi Syndrome
Figure 6. Noonan Syndrome
Figure 7. Others
Figure 8. Pediatric Growth Hormone Revenue Market Share by Application in 2021
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Others Picture
Figure 13. Global Pediatric Growth Hormone Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Pediatric Growth Hormone Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Pediatric Growth Hormone Revenue Market Share by Region (2017-2028)
Figure 16. Global Pediatric Growth Hormone Revenue Market Share by Region in 2021
Figure 17. North America Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Pediatric Growth Hormone Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Pediatric Growth Hormone Market Drivers
Figure 23. Pediatric Growth Hormone Market Restraints
Figure 24. Pediatric Growth Hormone Market Trends
Figure 25. Merck KGaA Recent Developments and Future Plans
Figure 26. Novo Nordisk A/S Recent Developments and Future Plans
Figure 27. Ferring B.V Recent Developments and Future Plans
Figure 28. Genentech, Inc. Recent Developments and Future Plans
Figure 29. Pfizer Inc. Recent Developments and Future Plans
Figure 30. Eli Lilly & Company Recent Developments and Future Plans
Figure 31. Novartis AG Recent Developments and Future Plans
Figure 32. BioPartners GmbH Recent Developments and Future Plans
Figure 33. Global Pediatric Growth Hormone Revenue Share by Players in 2021
Figure 34. Pediatric Growth Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Pediatric Growth Hormone Revenue Market Share in 2021
Figure 36. Global Top 10 Players Pediatric Growth Hormone Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Pediatric Growth Hormone Revenue Share by Indication in 2021
Figure 39. Global Pediatric Growth Hormone Market Share Forecast by Indication (2023-2028)
Figure 40. Global Pediatric Growth Hormone Revenue Share by Application in 2021
Figure 41. Global Pediatric Growth Hormone Market Share Forecast by Application (2023-2028)
Figure 42. North America Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 43. North America Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 44. North America Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 45. United States Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 49. Europe Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 50. Europe Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 51. Germany Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 57. Asia-Pacific Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Pediatric Growth Hormone Revenue Market Share by Region (2017-2028)
Figure 59. China Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 66. South America Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 67. South America Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Pediatric Growth Hormone Sales Market Share by Indication (2017-2028)
Figure 71. Middle East and Africa Pediatric Growth Hormone Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Pediatric Growth Hormone Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Pediatric Growth Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Merck KGaA
Novo Nordisk A/S
Ferring B.V
Genentech, Inc.
Pfizer Inc.
Eli Lilly & Company
Novartis AG
BioPartners GmbH
jiaGou

Add To Cart

gouMai

Buy Now